Spagnoletti, Gionata
 Distribuzione geografica
Continente #
NA - Nord America 1.735
EU - Europa 1.212
AS - Asia 292
AF - Africa 56
OC - Oceania 9
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.316
Nazione #
US - Stati Uniti d'America 1.722
DE - Germania 327
SE - Svezia 287
IT - Italia 188
CN - Cina 138
UA - Ucraina 107
IE - Irlanda 84
SG - Singapore 82
FR - Francia 56
CI - Costa d'Avorio 53
FI - Finlandia 34
GB - Regno Unito 32
IN - India 32
RU - Federazione Russa 30
PL - Polonia 24
IR - Iran 18
BE - Belgio 11
ES - Italia 11
AU - Australia 9
CA - Canada 7
BR - Brasile 6
JP - Giappone 5
MX - Messico 5
NL - Olanda 4
SI - Slovenia 4
CL - Cile 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HK - Hong Kong 3
PT - Portogallo 3
TR - Turchia 3
VN - Vietnam 3
CY - Cipro 2
EU - Europa 2
NO - Norvegia 2
SA - Arabia Saudita 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
BD - Bangladesh 1
BG - Bulgaria 1
BZ - Belize 1
DK - Danimarca 1
HU - Ungheria 1
KR - Corea 1
MD - Moldavia 1
MN - Mongolia 1
Totale 3.316
Città #
Chandler 479
Ashburn 146
Dublin 83
San Mateo 76
New York 73
Ann Arbor 64
Wilmington 61
Abidjan 53
Jacksonville 52
Milan 51
Singapore 47
Rome 43
Boston 39
Fairfield 39
Redwood City 37
Princeton 33
Dearborn 26
Moscow 24
Nanjing 23
Beijing 22
Warsaw 20
Lawrence 19
Nürnberg 18
Houston 17
Woodbridge 16
Los Angeles 15
Augusta 12
Marseille 12
Andover 11
Brussels 11
Hangzhou 11
Boardman 10
Nanchang 10
Zhengzhou 10
Seattle 9
Hebei 8
Helsinki 8
Shenyang 8
Bremen 7
Redmond 7
Costa Mesa 6
Lancaster 6
Pune 6
São Paulo 6
Washington 6
Cambridge 5
Cattolica 5
Fremont 5
Guangzhou 5
Kish 5
Norwalk 5
Tokyo 5
Bologna 4
Mexico 4
Mountain View 4
Romainville 4
San Diego 4
San Francisco 4
Shanghai 4
Tianjin 4
University Park 4
Bangalore 3
Brno 3
Busto Arsizio 3
Changsha 3
Jiaxing 3
Kraków 3
Leawood 3
London 3
Sydney 3
Wuhan 3
Acquaviva delle Fonti 2
Amsterdam 2
Ardabil 2
Bolzano 2
Changchun 2
Groningen 2
Haikou 2
Hanoi 2
Hong Kong 2
Izola 2
Jinan 2
Kochi 2
Kunming 2
Lanzhou 2
Lappeenranta 2
Las Vegas 2
Ljubljana 2
Lomazzo 2
Martinsicuro 2
Monmouth Junction 2
Montreal 2
Munich 2
Nicosia 2
Oslo 2
Phoenix 2
Porto 2
San Jose 2
Santa Clara 2
Saronno 2
Totale 1.899
Nome #
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: results from a preliminary cross-sectional study 138
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors. 114
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 114
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 113
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 108
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 97
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 89
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 89
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 89
LAPDOCTOR: TELL ME HOW DIFFICULT WILL BE MY DONOR 88
AN EASY ALGORITHM TO OPTIMIZE THE EXPOSURE TO TACROLIMUS AND EVEROLIMUS, WHEN USED IN COMBINATION 85
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 84
Metabolic Syndrome and Cardiovascular Disease in Kidney Transplantation 82
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 82
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 81
COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VERSUS LCPT 75
CHYLOUS ASCITES AFTER LAPAROSCOPIC LIVING DONOR NEPHRECTOMY. CASE REPORT AND REVIEW OF THE LITERATURE 74
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: Results from a preliminary cross-sectional study 72
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 70
Once-a-day administration of everolimus is safe in de novo renal transplant recipients: 1-year results of a pilot study 69
Evolution of causes of mortality in renal transplantation in the last 10 years 68
Living Kidney Donation in a Type 1 Dent's Disease Patient from His Mother 66
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 65
TO TRANSPLANT OR NOT TO TRANSPLANT: A KIDNEY WITH A GIANT CYST. CASE REPORT AND REVIEW OF THE LITERATURE 64
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy. 63
How Challenging Will Be My Living Donor? CT Scan and Clinical Evaluation Can Predict Technical Difficulty of Laparoscopic Donor Nephrectomy 62
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 61
Massive Coronary Microvascular Dysfunction in Severe Anderson-Fabry Disease Cardiomyopathy 59
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 59
Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in Dc Novo Kidney Transplant Recipients: ER-Tac vs LCPT 57
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 56
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study 55
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 54
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors 53
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 51
Behavioural and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 50
Behavioral and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 50
A 3-month, multicenter, randomized, open-label study to evaluate the impact on wound healing of the early (vs delayed) introduction of everolimus in De Novo Kidney transplant recipients, with a follow-up evaluation at 12 months after transplant (NEVERWOUND study) 48
Thymoglobuline plus basiliximab a mixed cocktail to start? 48
Metabolic syndrome and cardiovascular disease in kidney transplantation 47
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 45
Radiofrequency thermal ablation of renal graft neoplasms: Case series and literature review 45
Incidence of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients Immunosuppressed With Sirolimus in Combination With Cyclosporine 44
Are there any relations among transplant centre volume, surgical technique and anatomy for donor graft selection? Ten-year multicentric Italian experience on mini-invasive living donor nephrectomy 40
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy 38
Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine 37
Severe silent myocardial ischemia during echocardiographic examination in a patient during cardiac screening for a kidney transplant intervention 34
Higher Incidence of Acute Rejection in Renal Transplant Recipients With Low Everolimus Exposure 33
Long-Term Clinical Impact of Vesicoureteral Reflux in Kidney Transplantation 31
Prospective Clinical Trial Comparing Two Immunosuppressive Regimens, Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine, in De Novo Renal Transplant Recipients: Results at 6 Months Follow-up 28
Elderly kidney transplant recipient with intermittent fever: A case report of leishmaniasis with acute kidney injury during liposomal amphotericin B therapy 16
Induction With Basiliximab Plus Thymoglobulin Is Effective and Safe in Old-for-Old Renal Transplantation: Six-Month Results of a Prospective Clinical Study 15
Risk of Kaposi Sarcoma after Solid-Organ Transplantation: Multicenter Study in 4767 Recipients in Italy, 1970-2006 11
High-dose atorvastatin reduces oxidative stress of ischemia/reperfusion injury after isogeneic kidney transplantation in rats: in vivo, preclinical, case–control, open-label study 4
Systematic use of magnetic double J stent in pediatric kidney transplantation: A single-center experience 2
Neurologic outcome following liver transplantation for methylmalonic aciduria 1
Case report: Pylorus-preserving pancreatoduodenectomy for focal congenital hyperinsulinism in a 5-month-old baby 1
Totale 3.374
Categoria #
all - tutte 14.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020240 0 0 19 3 6 11 29 4 23 9 78 58
2020/2021394 36 32 15 32 55 33 38 10 46 14 72 11
2021/2022504 36 29 11 16 19 19 16 86 20 36 101 115
2022/20231.170 149 169 68 209 57 146 73 96 157 5 24 17
2023/2024471 29 126 11 51 22 87 24 24 5 14 32 46
2024/202581 28 53 0 0 0 0 0 0 0 0 0 0
Totale 3.374